Helena Van Damme

3PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Sana M Arnouk, Daliya Kancheva, Helena Van Damme

|Aug 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

Aleksandar Murgaski, Máté Kiss, Helena Van Damme

|Feb 16, 2021
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.

Helena Van Damme, Bruno Dombrecht, Máté Kiss

Pageof 1

Frequent Collaborators

2 joint publications

Aleksandar Murgaski

2 joint publications

Máté Kiss

2 joint publications

Daliya Kancheva

2 joint publications

Damya Laoui